Q2 2025 Total Revenue of $154.7M, up 18% at CER
Amicus Therapeutics Announces Second Quarter 2025 Financial Results and Corporate Updates
Seeking Alpha / 17 hours ago 1 Views
Seeking Alpha / 17 hours ago 1 Views
Q2 2025 Total Revenue of $154.7M, up 18% at CER
Comments